Chambers Review
Provided by Chambers
Corporate/M&A (PRC Firms) - China
What the Team is Known For
FenXun Partners has a proven track record in the market for its handling of complex inbound and outbound M&A projects. It routinely advises multinationals on the corporate law aspects of their business operations in China, including companies from the chemical and mechanical engineering sectors. The firm is part of a joint operation with Baker McKenzie, which affords it access to a global network of offices and expertise.
Strengths
FenXun has a global connection and can quickly allocate international resources to resolve complex matters.
They are professional, highly intelligent and highly competent. They stand out for being extremely hard-working and responsive.
Work Highlights
FenXun Partners advised GSK on its exclusive strategic partnership with Chongqing Zhifei Biological Products to promote GSK’s shingles vaccine Shingrix.
Notable practitioners
Zhang Hong's solid knowledge makes her the linchpin in a wide variety of corporate/M&A transactions. Dual-qualified in New York and the PRC, she is frequently sought after by clients to deal with cross-border investments, joint ventures and strategic cooperation.
业务优势
奋迅律师事务所在处理复杂的境内外并购项目方面拥有良好的市场业绩。该所经常为跨国公司（包括化学和机械工程行业的公司）在中国业务运营的公司法方面提供咨询。该所是与贝克·麦坚时联营的一部分，使其能够利用全球办事处网络和专业知识。
市场评价
奋迅拥有全球网络，可以快速配置国际资源来解决复杂问题。
律所专业、高度智能化且能力强。他们以非常勤奋和反应迅速而脱颖而出。
业务亮点
奋迅律师事务所为葛兰素史克就其与重庆智飞生物建立独家战略合作伙伴关系提供法律服务，该合作以推广葛兰素史克的带状疱疹疫苗 Shingrix疫苗。
领先律师
张宏律师扎实的知识使她成为各种企业并购交易的关键。她拥有纽约州和中国的双重执业资格，经常受到客户的追捧以处理跨境投资、合资企业和战略合作事宜。